Adage Capital Partners Gp, L.L.C. Revolution Medicines, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 397,400 shares of RVMD stock, worth $18.5 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
397,400
Previous 394,000
0.86%
Holding current value
$18.5 Million
Previous $13.9 Million
4.95%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding RVMD
# of Institutions
333Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$734 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$667 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$625 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$493 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$478 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.08B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...